Whalesbook
BSE Approves Trading for Regency Fincorp's New Shares
Regency Fincorp Limited announced it has received approval from the BSE (Bombay Stock Exchange) for the trading of 66.20 lakh equity shares. These shares represent a capital infusion of ₹14.56 crore and are set to begin trading on March 30, 2026. The approval, dated March 27, 2026, follows the conversion of warrants into equity.
Share Issuance Details
Regency Fincorp obtained the BSE approval for 66,20,201 equity shares. The shares were issued at ₹22 each (comprising a ₹10 face value and ₹12 premium) through a preferential process following warrant conversions. This issuance generated total proceeds of ₹14.56 crore. Trading for these shares is scheduled to start on March 30, 2026.
Impact on the Company
This capital infusion is expected to bolster Regency Fincorp's balance sheet and expand its lending capabilities. The listing of new shares will grow the company's equity base and enhance its stock's market availability. It also offers liquidity to shareholders who converted their warrants into equity.
Background and Wider Strategy
Earlier, in December 2024, Regency Fincorp allotted more than 4.33 crore warrants convertible into equity shares, primarily to promoters and non-promoters on a preferential basis. The current conversion of 66.20 lakh warrants into equity shares at ₹22 each is a continuation of this capitalisation effort. Beyond equity, the company has been active in debt markets, including a recent ₹25 crore NCD issuance with a 14% coupon rate. It also has board approval to raise up to ₹500 crore through NCDs for FY2026-27. Regency Fincorp is also diversifying into digital payment solutions.
Immediate Effects
The issuance will increase Regency Fincorp's total outstanding equity shares. Shareholders who converted warrants can now trade their holdings on the BSE. This also enhances the company's equity base and net worth, with expectations of improved market liquidity for its stock.
Industry Context
Regency Fincorp operates within the NBFC sector, alongside major players such as Bajaj Finance, Cholamandalam Investment, Muthoot Finance, Mahindra & Mahindra Financial Services, and L&T Finance Holdings. The use of instruments like preferential allotments and warrant conversions for capital raising and regulatory compliance is a common strategy among these peers.
Looking Ahead
Investors will be watching the trading activity and price performance of the new shares after March 30, 2026. Key areas to track include how Regency Fincorp utilizes the infused capital for business growth, its progress in expanding digital payment solutions, and any future fundraising activities, such as the planned ₹500 crore NCD program.